Literature DB >> 22399574

Factors affecting chronic obstructive pulmonary disease early rehospitalization.

T Nantsupawat1, C Limsuwat, K Nugent.   

Abstract

The Centers for Medicare and Medicaid Services has identified early rehospitalization of patients with chronic obstructive pulmonary disease (COPD) exacerbations as a performance measure for hospital care. We retrospectively reviewed patients with COPD who were admitted to University Medical Center, Lubbock, Texas, USA, between October 2010 and March 2011. There were 81 COPD patients with 103 hospitalizations. The mean age was 73.9 years. Pulmonary function tests using the Global initiative for chronic Obstructive Lung Disease criteria had been done in 36 patients (44.4%) and revealed 1 mild (2.8%), 7 moderate (19.4%), 20 severe (55.6%), and 8 very severe (22.2%) cases. Only 38.4% of the patients had prior influenza vaccine. Most patients were treated with antibiotics (81.8%) and corticosteroids (87.9%). The mean length of stay was 4.9 days, and 4 patients died. Most of the patients were discharged home (63.6%) with a median follow-up interval of 14 days. Thirty-two percent did not have long-acting bronchodilators and/or inhaled corticosteroids prescribed on discharge. There were 14 early rehospitalizations within 30 days. Logistic regression analysis indicated that a history of coronary artery disease (odds ratio (OR) 6.4, 95% confidence interval (CI) 1.1-37.4) and unilateral pulmonary infiltrates (OR 12.8, 95% CI 1.9-86.4) significantly increased the early rehospitalization rates. Acute exacerbations of COPD in patients with a history of ischemic heart disease or unilateral pulmonary infiltrates are at increased risk for early readmission. These risk factors should be identified during hospitalization; early follow-up or other interventions may reduce readmissions. Influenza vaccine, maintenance bronchodilators and/or inhaled corticosteroids, and pulmonary function tests were underused, and these standards of care should be provided to improve care.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399574     DOI: 10.1177/1479972312438703

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  13 in total

1.  Effect of pharmacist-led inhaler technique assessment service on readmissions in hospitalized COPD patients: a randomized, controlled pilot study.

Authors:  Adyam Tesfamariam Kebede; Elin Trapnes; Marianne Lea; Bjørg Abrahamsen; Liv Mathiesen
Journal:  BMC Pulm Med       Date:  2022-05-27       Impact factor: 3.320

2.  Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease.

Authors:  Tzy-Chyi Yu; Huanxue Zhou; Kangho Suh; Stephen Arcona
Journal:  Clinicoecon Outcomes Res       Date:  2015-01-06

3.  The association between glucose levels and hospital outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Ebtesam A Islam; Chok Limsuwat; Teerapat Nantsupawat; Gilbert G Berdine; Kenneth M Nugent
Journal:  Ann Thorac Med       Date:  2015 Apr-Jun       Impact factor: 2.219

Review 4.  Acute exacerbations of COPD: risk factors for failure and relapse.

Authors:  Marco Mantero; Paola Rogliani; Marta Di Pasquale; Eva Polverino; Ernesto Crisafulli; Monica Guerrero; Andrea Gramegna; Mario Cazzola; Francesco Blasi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-09-08

5.  Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists.

Authors:  Vamsi Bollu; Annie Guérin; Geneviève Gauthier; Robert Hiscock; Eric Q Wu
Journal:  Drugs Real World Outcomes       Date:  2017-03

6.  Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates.

Authors:  Abdulmajeed Alshabanat; Michael C Otterstatter; Don D Sin; Jeremy Road; Carmen Rempel; Jane Burns; Stephan F van Eeden; J M FitzGerald
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-03-21

7.  Factors Associated With Nonreceipt of Recommended COPD Medications: A Population Study.

Authors:  Andrea S Gershon; Priscila Pequeno; Amanda Alberga Machado; Shawn D Aaron; Tetyana Kendzerska; Jin Luo; Matthew B Stanbrook; Wan C Tan; Joan Porter; Teresa To
Journal:  Chest       Date:  2021-06-16       Impact factor: 9.410

8.  Risk assessment of readmissions following an initial COPD-related hospitalization.

Authors:  Christine L Baker; Kelly H Zou; Jun Su
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-11-12

9.  Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data.

Authors:  Christine L Baker; Kelly H Zou; Jun Su
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-03

10.  Bacterial etiology in early re-admission patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Jian Lin; Su-Su He; You-Zu Xu; Hai-Yan Li; Xiao-Mai Wu; Jia-Xi Feng
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.